Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX07 Combined with Chemotherapy in Advanced Solid Tumors
NCT03577704Phase 2Completed
- Sponsor
- Henlius
- Start
- Aug 2018
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pimurutamab in solid tumor, sponsored by Henlius. Started Aug 2018; status: completed.
02
Drugs
pimurutamab
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03577704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03577704.